Literature DB >> 8494358

Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics.

C Chuard1, P Vaudaux, F A Waldvogel, D P Lew.   

Abstract

Several recent studies have shown that bacteria either grown in vitro as adherent biofilms or recovered from infected prosthetic devices have decreased susceptibilities to antimicrobial killing. To further study the microbial and environmental factors responsible for this decreased antibiotic susceptibility, we developed an in vitro model of surface-adherent Staphylococcus aureus growing on polymethylmethacrylate coverslips coated with pure fibronectin. After exponential growth for 4 h, the population of fibronectin-attached S. aureus remained constant for a further 48-h period, as evaluated by CFU counts of organisms quantitatively removed from the coverslips. At selected time points, surface-bound organisms were exposed to bactericidal concentrations of either oxacillin, vancomycin, fleroxacin, or gentamicin in short-term (0.5 to 2 h) or long-term (24 h) killing assays. Whereas at 2 h surface-growing organisms were still optimally killed by all antimicrobial agents, at 4 and 24 h attached bacteria expressed markedly altered susceptibilities to these agents. The decrease in susceptibility was moderate for fleroxacin, more important for oxacillin and vancomycin, and extensive for gentamicin. When surface-attached S. aureus was compared with bacteria grown in a fluid phase, both populations showed a parallel time-dependent decrease in their susceptibilities to either oxacillin, vancomycin, or fleroxacin. In contrast, attached organisms became considerably more resistance to gentamicin than suspended bacteria did. Subpopulations of organisms spontaneously released from coverslips during antibiotic exposure also showed markedly reduced susceptibilities to antimicrobial killing. This simple model of S. aureus colonization of in vitro fibronectin-coated surfaces might represent a useful approach to the study of the physiological and biochemical changes that underlie the decreased antibiotic susceptibilities of biomaterial-attached organisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494358      PMCID: PMC187725          DOI: 10.1128/AAC.37.4.625

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals.

Authors:  D M Musher; R E Baughn; G B Templeton; J N Minuth
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

2.  Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus.

Authors:  P Vaudaux; R Suzuki; F A Waldvogel; J J Morgenthaler; U E Nydegger
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

3.  Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections.

Authors:  A F Widmer; A Wiestner; R Frei; W Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

4.  Adsorption of fibronectin onto polymethylmethacrylate and promotion of Staphylococcus aureus adherence.

Authors:  P E Vaudaux; F A Waldvogel; J J Morgenthaler; U E Nydegger
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

5.  Virulent gentamicin-induced small colony variants of Staphylococcus aureus.

Authors:  L L Pelletier; M Richardson; M Feist
Journal:  J Lab Clin Med       Date:  1979-08

6.  Pathogenesis of foreign body infection. Evidence for a local granulocyte defect.

Authors:  W Zimmerli; P D Lew; F A Waldvogel
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus.

Authors:  M H Miller; S C Edberg; L J Mandel; C F Behar; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

8.  Pathogenesis of foreign body infection: description and characteristics of an animal model.

Authors:  W Zimmerli; F A Waldvogel; P Vaudaux; U E Nydegger
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

9.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.

Authors:  G D Christensen; W A Simpson; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.

Authors:  J C Nickel; I Ruseska; J B Wright; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

View more
  18 in total

Review 1.  [Treatment of infected total knee arthroplasty. When does implant salvage make sense?].

Authors:  T Kern; H Gollwitzer; M Militz; V Bühren
Journal:  Orthopade       Date:  2006-09       Impact factor: 1.087

2.  Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.

Authors:  K Sieradzki; R B Roberts; D Serur; J Hargrave; A Tomasz
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

3.  Measuring Antimicrobial Efficacy against Biofilms: a Meta-analysis.

Authors:  Philip S Stewart; Albert E Parker
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

4.  Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers.

Authors:  Sandra Reilley; Eric Wenzel; Laurie Reynolds; Beth Bennett; Joseph M Patti; Seth Hetherington
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Practical considerations in the use of outpatient antimicrobial therapy for musculoskeletal infections.

Authors:  Camelia E Marculescu; Elie F Berbari; J Robert Cantey; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

6.  Ultrasonic enhancement of antibiotic action on gram-negative bacteria.

Authors:  W G Pitt; M O McBride; J K Lunceford; R J Roper; R D Sagers
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.

Authors:  Christian Joukhadar; Satish Pillai; Christine Wennersten; Robert C Moellering; George M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

Review 8.  [Postoperative and bacterial osteitis. New possibilities for therapy].

Authors:  V Heppert; U Glatzel; A Wentzensen
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

9.  Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.

Authors:  Andrea E Hall; Paul J Domanski; Pratiksha R Patel; John H Vernachio; Peter J Syribeys; Elena L Gorovits; Michael A Johnson; Julia M Ross; Jeff T Hutchins; Joseph M Patti
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.

Authors:  P Vaudaux; T Ferry; I Uçkay; P François; J Schrenzel; S Harbarth; A Renzoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-26       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.